Virtus LifeSci Biotech Clinical Trials ETF Rating $29.24 +0.45 (+1.56%) (As of 11/4/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy2.91Holdings in BBC have an aggregate rating of Moderate Buy based on 405 analyst ratings issued in the past year covering 49 companies (55.9% of the portfolio).BBC Aggregate Price Target$44.8653.41% UpsideHigh Prediction$61.11Average Prediction$44.86Low Prediction$29.93Holdings in BBC have an aggregate price target of $44.86 and a range of $29.93 to $61.11 covering 49 companies (55.9% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy28 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.38%SRRKScholar Rock$27.67-2.6%4.6821 of 5 stars3.14$33.29 20.3%7Upcoming EarningsAnalyst Forecast2.30%LBPHLongboard Pharmaceuticals$59.50-0.3%1.7136 of 5 stars2.44$59.56 0.1%9Upcoming Earnings1.96%SMMTSummit Therapeutics$19.96+5.1%2.7095 of 5 stars2.67$35.67 78.7%4Analyst ForecastGap Up1.76%WVEWave Life Sciences$13.79-0.3%4.9495 of 5 stars3.00$19.44 41.0%10Analyst Forecast1.69%IGMSIGM Biosciences$15.69-3.3%3.6593 of 5 stars2.33$15.00 -4.4%9Upcoming Earnings1.48%EWTXEdgewise Therapeutics$34.48+1.4%1.9734 of 5 stars3.00$35.60 3.2%5Positive News1.43%VRDNViridian Therapeutics$22.84+2.5%2.606 of 5 stars2.82$35.80 56.7%11Upcoming Earnings1.39%PRAXPraxis Precision Medicines$70.02+2.5%3.1747 of 5 stars2.89$145.67 108.0%9Upcoming Earnings1.28%APLTApplied Therapeutics$9.26+1.9%4.226 of 5 stars3.17$12.50 35.0%61.25%ACLXArcellx$86.44+0.3%1.4602 of 5 stars3.08$89.75 3.8%13Upcoming Earnings1.22%BHVNBiohaven$50.04-1.7%3.0835 of 5 stars3.07$61.92 23.7%14Upcoming EarningsPositive News1.20%CNTACentessa Pharmaceuticals$15.89+1.4%3.0771 of 5 stars3.00$25.17 58.4%6Upcoming Earnings1.18%NRIXNurix Therapeutics$25.04+2.3%1.5979 of 5 stars2.93$29.40 17.4%151.17%PCVXVaxcyte$106.49-0.7%3.257 of 5 stars3.00$147.50 38.5%7Insider SellingPositive News1.12%ANABAnaptysBio$19.94-8.0%2.976 of 5 stars2.83$55.73 179.5%12Upcoming Earnings1.11%ZYMEZymeworks$14.76+11.1%1.0748 of 5 stars2.50$17.00 15.2%4Earnings ReportAnalyst Forecast1.11%SLRNAcelyrin$5.82+3.6%2.8768 of 5 stars2.50$11.17 91.9%61.10%SAVACassava Sciences$25.84-1.4%3.7022 of 5 stars3.00$111.50 331.5%2Upcoming Earnings1.09%TYRATyra Biosciences$16.42+0.2%3.7507 of 5 stars3.00$31.40 91.2%5Upcoming EarningsInsider BuyingGap Up1.08%NMRANeumora Therapeutics$11.71+4.8%1.9716 of 5 stars2.86$22.83 95.0%7Upcoming Earnings1.07%KYMRKymera Therapeutics$47.07+1.3%0.9387 of 5 stars2.80$50.93 8.2%15Earnings ReportAnalyst ForecastAnalyst Revision1.05%COGTCogent Biosciences$11.87+1.3%1.4609 of 5 stars2.71$14.67 23.6%7Upcoming EarningsAnalyst Forecast1.04%PTGXProtagonist Therapeutics$46.763.6977 of 5 stars3.17$52.83 13.0%7Upcoming EarningsAnalyst Forecast1.02%ELVNEnliven Therapeutics$27.65+0.1%1.1858 of 5 stars3.25$34.33 24.2%41.00%IRONDisc Medicine$58.25+23.6%3.7648 of 5 stars3.00$73.10 25.5%10Analyst ForecastNews CoverageGap UpHigh Trading Volume1.00%NUVLNuvalent$89.53+0.3%3.3964 of 5 stars2.85$112.40 25.5%13Insider SellingNews Coverage0.98%ABUSArbutus Biopharma$3.87-2.3%1.5365 of 5 stars3.00$5.25 35.7%4Upcoming Earnings0.98%QUREuniQure$5.56-5.1%2.0462 of 5 stars2.67$19.50 250.7%60.98%REPLReplimune Group$12.02+1.0%3.6664 of 5 stars3.17$16.80 39.8%6Upcoming Earnings0.98%CRNXCrinetics Pharmaceuticals$56.82+0.2%2.9935 of 5 stars2.91$68.55 20.6%11Negative News0.97%ANNXAnnexon$7.09-2.6%1.3979 of 5 stars3.00$15.80 122.8%6Upcoming Earnings0.96%JANXJanux Therapeutics$55.87+2.7%2.9391 of 5 stars2.90$66.44 18.9%10Upcoming Earnings0.95%PHVSPharvaris$23.93-0.9%2.0094 of 5 stars2.60$33.60 40.4%5Upcoming Earnings0.94%PLRXPliant Therapeutics$14.49-0.2%4.0812 of 5 stars3.11$40.57 180.0%90.94%ERASErasca$2.87+5.5%2.0255 of 5 stars2.80$6.10 112.5%50.94%CRGXCARGO Therapeutics$21.20+4.1%1.8433 of 5 stars3.00$30.33 43.1%7Positive News0.93%APGEApogee Therapeutics$56.30+3.3%2.5203 of 5 stars3.00$78.50 39.4%6Upcoming Earnings0.93%AKROAkero Therapeutics$32.05-0.9%3.8742 of 5 stars2.86$43.20 34.8%7Upcoming Earnings0.92%BLTEBelite Bio$69.71-0.3%0.627 of 5 stars3.00$59.00 -15.4%4Upcoming EarningsNews CoverageHigh Trading Volume0.92%DNLIDenali Therapeutics$27.21+0.6%4.3834 of 5 stars2.73$38.90 43.0%11Gap Up0.92%KROSKeros Therapeutics$59.95+0.0%3.4367 of 5 stars3.00$89.11 48.6%11Positive News0.92%RVMDRevolution Medicines$55.87+1.4%3.1873 of 5 stars3.08$56.75 1.6%12Upcoming Earnings0.92%NGNENeurogene$66.00+43.3%0.8605 of 5 stars3.11$51.00 -22.7%9News CoverageGap UpHigh Trading Volume0.92%VKTXViking Therapeutics$63.14-13.4%4.2048 of 5 stars3.09$109.80 73.9%11Analyst ForecastNews CoverageGap UpHigh Trading Volume0.92%SLNOSoleno Therapeutics$56.14+0.5%3.9151 of 5 stars3.13$69.86 24.4%80.91%RNAAvidity Biosciences$44.82+7.0%2.0075 of 5 stars3.00$63.22 41.1%90.87%ORICORIC Pharmaceuticals$9.48+0.7%4.1746 of 5 stars3.00$18.29 92.9%8Analyst ForecastNews Coverage0.87%MLTXMoonLake Immunotherapeutics$46.40-0.8%2.0549 of 5 stars2.82$80.45 73.4%11Upcoming Earnings0.87%XENEXenon Pharmaceuticals$41.71+0.0%3.5496 of 5 stars3.08$57.45 37.7%12Positive News This page (NYSEARCA:BBC) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBC Stock Alerts